Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candidaspecies
Authors:
- Graziella H. PereiraGPGraziella H. Pereira
- Patrícia Rady MüllerPMPatrícia Rady Müller
- Maria Walderez SzeszsMSMaria Walderez Szeszs
- Anna S. LevinALAnna S. Levin
- Márcia S. C. MelhemMMMárcia S. C. Melhem
- 1 September 2010
- journal article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 48 (6) , 839-842
Abstract
This is a retrospective observational study of clinical and epidemiologic data from bloodstream yeast infections over 5 years (2004-2008) in a tertiary-care hospital. During this period, there were 52 such infections, at a rate of 2.4 per 1,000 hospital admissions. Non-C. albicans Candida species and other genera were responsible for 82% of infections, with C. tropicalis and C. parapsilosis being the most common. In 2008 no C. albicans infections occurred. Several uncommon fungal pathogens were observed, including Trichosporon asahii, Rhodotorula spp. and Candida zeylanoides. Of 16 isolates tested, 3 (19%) were resistant to fluconazole, including one C. zeylanoides (MIC 8 microg/ml) and one C. tropicalis (MIC 16 microg/ml) isolate, as well as intrinsically resistant C. krusei. All isolates tested were susceptible to itraconazole (n = 7) and amphotericin B (n = 8). Yeast infections were associated with severe underlying diseases, mainly hematological/solid cancers (71%), hospitalization in the ICU (41%), central venous catheters (80%), and use of antimicrobials (94%). The overall mortality rate was 50%. Our finding of a predominance of non-C. albicans Candida species infection with uncommon yeasts, and fluconazole resistance, suggests the need for continuous surveillance of fungemia and of antibiotic susceptibility trends, in order to adopt treatment strategies applicable to particular healthcare institutions.Keywords
This publication has 22 references indexed in Scilit:
- Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance RegistryClinical Infectious Diseases, 2009
- Red Regional de Laboratorios para la Vigilancia de las Infecciones Fúngicas Invasoras y Susceptibilidad a los AntifúngicosRevista Panamericana de Salud Pública, 2008
- Comparison between Disk Diffusion and Microdilution Methods for Determining Susceptibility of Clinical Fungal Isolates to CaspofunginJournal of Clinical Microbiology, 2007
- Prospective Observational Study of Candidemia in São Paulo, Brazil: Incidence Rate, Epidemiology, and Predictors of MortalityInfection Control & Hospital Epidemiology, 2007
- Antifungal Drug Susceptibility Profile of Pichia anomala Isolates from Patients Presenting with Nosocomial FungemiaAntimicrobial Agents and Chemotherapy, 2007
- Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995–2003Diagnostic Microbiology and Infectious Disease, 2007
- Etiology of fungaemia and catheter colonisation in Argentinean paediatric patientsMycoses, 2005
- A 9-year Study Comparing Risk Factors and the Outcome of Paediatric and Adults with Nosocomial CandidaemiaMycopathologia, 2005
- Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance StudyClinical Infectious Diseases, 2004
- Nosocomial fungaemia: a 2-year prospective studyJournal of Hospital Infection, 2000